Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

New treatment option arrives for Canadians with sleep apnea and obesity

Summary by CTV News
Health Canada has approved Zepbound as the first medication in Canada specifically indicated for adults with obesity and moderate-to-severe obstructive sleep apnea. The decision introduces a new treatment option for a condition that affects sleep quality and is linked to several serious health risks.

1 Articles

CTV NewsCTV News
Center

New treatment option arrives for Canadians with sleep apnea and obesity

Health Canada has approved Zepbound as the first medication in Canada specifically indicated for adults with obesity and moderate-to-severe obstructive sleep apnea. The decision introduces a new treatment option for a condition that affects sleep quality and is linked to several serious health risks.

·Canada
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

CTV News broke the news in Canada on Monday, June 22, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Obesity icon

Obesity

Health Canada icon

Health Canada

Canada icon

Canada

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal